{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:43:17Z","timestamp":1791024197765,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.bbalip.2011.10.010","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T21:58:15Z","timestamp":1319666295000},"page":"782-789","source":"Crossref","is-referenced-by-count":141,"title":["Regulation of triglyceride metabolism by Angiopoietin-like proteins"],"prefix":"10.1016","volume":"1821","author":[{"given":"Frits","family":"Mattijssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Kersten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbalip.2011.10.010_bb0380","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cmet.2009.08.003","article-title":"Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance","volume":"10","author":"Tabata","year":"2009","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0385","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1210\/en.2010-1407","article-title":"Angiopoietin-like 2, a circadian gene, improves type 2 diabetes through potentiation of insulin sensitivity in mice adipocytes","volume":"152","author":"Kitazawa","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2011.10.010_bb0390","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0395","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng.75","article-title":"Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans","volume":"40","author":"Kathiresan","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0400","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia","volume":"41","author":"Kathiresan","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0405","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1093\/hmg\/ddp361","article-title":"A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia","volume":"18","author":"Hegele","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0410","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbalip.2011.10.010_bb0415","article-title":"Comparative analysis of genome-wide-association studies signals for lipids, diabetes, and coronary heart disease: Cardiovascular Biomarker Genetics Collaboration","author":"Angelakopoulou","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0420","first-page":"70","article-title":"Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans","volume":"119","author":"Romeo","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0425","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","article-title":"Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia","volume":"363","author":"Musunuru","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000098153","article-title":"Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects","volume":"44","author":"Hatsuda","year":"2007","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0010","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.ATV.0000252827.51626.89","article-title":"Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase","volume":"27","author":"Shimamura","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1258\/acb.2010.009307","article-title":"Association of angiopoietin-like protein 3 with hepatic triglyceride lipase and lipoprotein lipase activities in human plasma","volume":"47","author":"Nakajima","year":"2010","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0020","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1194\/jlr.M002618","article-title":"Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample","volume":"51","author":"Robciuc","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng814","article-title":"Angptl3 regulates lipid metabolism in mice","volume":"30","author":"Koishi","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0030","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1210\/en.2005-0476","article-title":"Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism","volume":"146","author":"Koster","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bbalip.2011.10.010_bb0035","doi-asserted-by":"crossref","first-page":"33742","DOI":"10.1074\/jbc.M203215200","article-title":"ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase","volume":"277","author":"Shimizugawa","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0040","doi-asserted-by":"crossref","first-page":"41804","DOI":"10.1074\/jbc.M302861200","article-title":"Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo","volume":"278","author":"Ono","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0045","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1074\/jbc.M808477200","article-title":"The angiopoietin-like proteins ANGPTL3 and ANGPTL4 inhibit lipoprotein lipase activity through distinct mechanisms","volume":"284","author":"Shan","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0050","doi-asserted-by":"crossref","first-page":"27561","DOI":"10.1074\/jbc.M110.144279","article-title":"Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases","volume":"285","author":"Liu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0055","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1194\/jlr.M900145-JLR200","article-title":"GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4","volume":"50","author":"Sonnenburg","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0060","doi-asserted-by":"crossref","first-page":"11942","DOI":"10.1074\/jbc.M809802200","article-title":"A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization","volume":"284","author":"Yau","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cmet.2007.07.009","article-title":"Hepatic proprotein convertases modulate HDL metabolism","volume":"6","author":"Jin","year":"2007","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0070","doi-asserted-by":"crossref","first-page":"36293","DOI":"10.1074\/jbc.M110.156950","article-title":"O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids","volume":"285","author":"Schjoldager","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0075","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1194\/jlr.M500005-JLR200","article-title":"Differential regulation and properties of angiopoietin-like proteins 3 and 4","volume":"46","author":"Ge","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1194\/jlr.M200367-JLR200","article-title":"Regulation of the angiopoietin-like protein 3 gene by LXR","volume":"44","author":"Kaplan","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0085","doi-asserted-by":"crossref","first-page":"21344","DOI":"10.1074\/jbc.M213202200","article-title":"Angiopoietin-like protein 3 mediates hypertriglyceridemia induced by the liver X receptor","volume":"278","author":"Inaba","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0090","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2006.05.005","article-title":"Ligand-activated PPARbeta efficiently represses the induction of LXR-dependent promoter activity through competition with RXR","volume":"256","author":"Matsusue","year":"2006","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0095","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2796.2010.02305.x","article-title":"Effects of high-dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism","volume":"269","author":"Pramfalk","year":"2011","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0100","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.bbrc.2004.03.151","article-title":"ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states","volume":"317","author":"Inukai","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0105","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbrc.2004.08.024","article-title":"Leptin and insulin down-regulate angiopoietin-like protein 3, a plasma triglyceride-increasing factor","volume":"322","author":"Shimamura","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0110","doi-asserted-by":"crossref","first-page":"11553","DOI":"10.1074\/jbc.M512554200","article-title":"The lipoprotein lipase inhibitor ANGPTL3 is negatively regulated by thyroid hormone","volume":"281","author":"Fugier","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0115","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.bbrc.2009.12.145","article-title":"The acute phase response stimulates the expression of angiopoietin like protein 4","volume":"391","author":"Lu","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0120","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ng1984","article-title":"Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL","volume":"39","author":"Romeo","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0125","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/ATVBAHA.108.176917","article-title":"ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk","volume":"28","author":"Talmud","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0130","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.annepidem.2008.07.004","article-title":"Longitudinal changes in triglycerides according to ANGPTL4[E40K] genotype and longitudinal body weight change in the atherosclerosis risk in communities study","volume":"18","author":"Nettleton","year":"2008","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0135","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.metabol.2007.12.007","article-title":"Genetic variation within the ANGPTL4 gene is not associated with metabolic traits in white subjects at an increased risk for type 2 diabetes mellitus","volume":"57","author":"Staiger","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2011.10.010_bb0140","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1210\/jc.2009-0769","article-title":"Associations between common genetic polymorphisms in angiopoietin-like proteins 3 and 4 and lipid metabolism and adiposity in European adolescents and adults","volume":"94","author":"Legry","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1471-2350-12-89","article-title":"ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical Trial","volume":"12","author":"Smart-Halajko","year":"2011","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0150","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1161\/ATVBAHA.110.212209","article-title":"The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk","volume":"30","author":"Smart-Halajko","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0155","first-page":"59","article-title":"Angiopoietin-like protein 4: development, analytical characterization, and clinical testing of a new ELISA","volume":"27","author":"Stejskal","year":"2008","journal-title":"Gen. Physiol. Biophys."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0160","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2337\/db07-1438","article-title":"Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans","volume":"58","author":"Staiger","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2011.10.010_bb0165","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1194\/jlr.P015867","article-title":"Serum angiopoietin-like 4 protein levels and expression in adipose tissue are inversely correlated with obesity in monozygotic twins","volume":"52","author":"Robciuc","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0170","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1074\/jbc.M506519200","article-title":"The fasting-induced adipose factor\/angiopoietin-like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity","volume":"281","author":"Mandard","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0175","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1073\/pnas.0409564102","article-title":"Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart","volume":"102","author":"Yu","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0180","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCRESAHA.110.217380","article-title":"Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta\/delta and protects against fatty acid-induced oxidative stress","volume":"106","author":"Georgiadi","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0185","doi-asserted-by":"crossref","first-page":"11766","DOI":"10.1073\/pnas.0705041104","article-title":"Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice","volume":"104","author":"Desai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0190","doi-asserted-by":"crossref","first-page":"13735","DOI":"10.1074\/jbc.M807899200","article-title":"Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL)","volume":"284","author":"Lee","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0195","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1194\/jlr.C200010-JLR200","article-title":"Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase","volume":"43","author":"Yoshida","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0200","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1128\/MCB.00370-09","article-title":"Peroxisome proliferator-activated receptor beta\/delta (PPARbeta\/delta) but not PPARalpha serves as a plasma free fatty acid sensor in liver","volume":"29","author":"Sanderson","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0205","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1161\/ATVBAHA.107.151894","article-title":"Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake","volume":"27","author":"Lichtenstein","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0210","doi-asserted-by":"crossref","first-page":"17450","DOI":"10.1073\/pnas.0604026103","article-title":"Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue","volume":"103","author":"Sukonina","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0215","doi-asserted-by":"crossref","first-page":"15747","DOI":"10.1074\/jbc.M110.217638","article-title":"Proteolytic processing of angiopoietin-like protein 4 by proprotein convertases modulates its inhibitory effects on lipoprotein lipase activity","volume":"286","author":"Lei","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0220","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmet.2010.11.002","article-title":"Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages","volume":"12","author":"Lichtenstein","year":"2010","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0225","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/ATVBAHA.107.157776","article-title":"Suppression of the Raf\/MEK\/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4","volume":"28","author":"Yang","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0230","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1096\/fj.08-115170","article-title":"Interaction of the coiled-coil domain with glycosaminoglycans protects angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity","volume":"23","author":"Chomel","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0235","doi-asserted-by":"crossref","first-page":"13213","DOI":"10.1074\/jbc.M900553200","article-title":"Genetic variation in ANGPTL4 provides insights into protein processing and function","volume":"284","author":"Yin","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0240","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1074\/jbc.M307583200","article-title":"Oligomerization and regulated proteolytic processing of angiopoietin-like protein 4","volume":"279","author":"Ge","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0245","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2353\/ajpath.2010.100129","article-title":"Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration","volume":"177","author":"Goh","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0250","doi-asserted-by":"crossref","first-page":"32999","DOI":"10.1074\/jbc.M110.108175","article-title":"Angiopoietin-like 4 interacts with matrix proteins to modulate wound healing","volume":"285","author":"Goh","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0255","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1194\/jlr.M400138-JLR200","article-title":"Oligomerization state-dependent hyperlipidemic effect of angiopoietin-like protein 4","volume":"45","author":"Ge","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0260","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","article-title":"Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome","volume":"17","author":"Clement","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0265","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/ATVBAHA.108.182147","article-title":"Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids","volume":"29","author":"Kersten","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0270","doi-asserted-by":"crossref","first-page":"28488","DOI":"10.1074\/jbc.M004029200","article-title":"Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene","volume":"275","author":"Kersten","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0275","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2217\/17460875.1.2.227","article-title":"Fasting-induced adipose factor\/angiopoietin-like protein 4: a potential target for dyslipidemia?","volume":"1","author":"Zandbergen","year":"2006","journal-title":"Future Lipidol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0280","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1128\/MCB.20.14.5343-5349.2000","article-title":"Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation","volume":"20","author":"Yoon","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0285","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cell.2007.02.050","article-title":"Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors","volume":"129","author":"Schug","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bbalip.2011.10.010_bb0290","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1124\/mol.108.050625","article-title":"Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta\/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid","volume":"74","author":"Rieck","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0295","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/mol.109.060541","article-title":"15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta\/delta agonist","volume":"77","author":"Naruhn","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0300","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/mol.110.065508","article-title":"Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta\/delta antagonist GSK3787","volume":"78","author":"Palkar","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0305","doi-asserted-by":"crossref","first-page":"34411","DOI":"10.1074\/jbc.M403058200","article-title":"The direct peroxisome proliferator-activated receptor target fasting-induced adipose factor (FIAF\/PGAR\/ANGPTL4) is present in blood plasma as a truncated protein that is increased by fenofibrate treatment","volume":"279","author":"Mandard","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0310","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1186\/gb-2007-8-7-r147","article-title":"Meta-analysis of primary target genes of peroxisome proliferator-activated receptors","volume":"8","author":"Heinaniemi","year":"2007","journal-title":"Genome Biol."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0315","doi-asserted-by":"crossref","first-page":"29469","DOI":"10.1074\/jbc.M110.142018","article-title":"Transcriptional profiling identifies functional interactions of TGF beta and PPAR beta\/delta signaling: synergistic induction of ANGPTL4 transcription","volume":"285","author":"Kaddatz","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0320","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/nar\/gkq773","article-title":"Reverse crosstalk of TGFbeta and PPARbeta\/delta signaling identified by transcriptional profiling","volume":"39","author":"Stockert","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0325","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.bbrc.2006.07.032","article-title":"Insulin downregulates angiopoietin-like protein 4 mRNA in 3T3-L1 adipocytes","volume":"347","author":"Yamada","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0330","doi-asserted-by":"crossref","first-page":"25593","DOI":"10.1074\/jbc.M109.025452","article-title":"Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism","volume":"284","author":"Koliwad","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0335","article-title":"Intermittent hypoxia inhibits clearance of triglyceride-rich lipoproteins and inactivates adipose lipoprotein lipase in a mouse model of sleep apnoea","author":"Drager","year":"2011","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0340","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.0605374104","article-title":"Mechanisms underlying the resistance to diet-induced obesity in germ-free mice","volume":"104","author":"Backhed","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0345","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1017\/S0007114510001303","article-title":"Absence of intestinal microbiota does not protect mice from diet-induced obesity","volume":"104","author":"Fleissner","year":"2010","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0350","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013087","article-title":"Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4)","volume":"5","author":"Aronsson","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2011.10.010_bb0355","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.diabet.2008.12.005","article-title":"Association between angiopoietin-like 6 (ANGPTL6) gene polymorphisms and metabolic syndrome-related phenotypes in the French MONICA Study","volume":"35","author":"Legry","year":"2009","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0360","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.metabol.2010.05.013","article-title":"Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome","volume":"60","author":"Namkung","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2011.10.010_bb0365","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.metabol.2008.11.016","article-title":"Serum levels of angiopoietin-related growth factor in diabetes mellitus and chronic hemodialysis","volume":"58","author":"Ebert","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2011.10.010_bb0370","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nm1214","article-title":"Angiopoietin-related growth factor antagonizes obesity and insulin resistance","volume":"11","author":"Oike","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbalip.2011.10.010_bb0375","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molmed.2005.08.002","article-title":"Angiopoietin-like proteins: potential new targets for metabolic syndrome therapy","volume":"11","author":"Oike","year":"2005","journal-title":"Trends Mol. Med."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111002149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198111002149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T05:30:03Z","timestamp":1543469403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198111002149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1388198111002149"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2011.10.010","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}